Literature DB >> 21785887

[Certified prostate cancer centers and second opinion centers for testicular cancer: successful models of uro-oncology cancer care].

J E Gschwend1, P Albers, M Schrader.   

Abstract

Establishment of organ site-specific cancer centers by the German Cancer Society (GCS) is part of the basic politically driven reform of oncology care in Germany. Since 2007 an increasing number of prostate cancer centers have been guided toward certification by the OnkoZert GmbH of the GCS. Currently 68 centers are certified and together with ongoing certification proceedings will amount to 81 prostate cancer centers, which cover about one fourth of cases of primary prostate cancer. Urology is of particular importance in the management of these centers. For the most part, urologists belonging to a clinical unit are the initiators of the certification process, thus ensuring that uro-oncology is firmly entrenched in the specialty with involvement of outpatient service providers. Fears that authority will be lost are unfounded as long as responsibility for this task is taken seriously and active use is made of the possibilities for creativity. A similarly important function is fulfilled by the testicular cancer centers that offer second opinion services, which were initiated by urology conjointly with German Cancer Aid to pursue the goal of quality assurance for this tumor entity and therefore likewise secure the position of this tumor in the realm of urologists. By applying such strategic approaches, urologists will succeed in sustainably safeguarding their future importance in a very competitive environment and in counteracting the encroachments of other specialties by exhibiting clear orientation.

Entities:  

Mesh:

Year:  2011        PMID: 21785887     DOI: 10.1007/s00120-011-2540-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  4 in total

1.  ["Second opinion centers". Approach for improving the quality of treatment for testicular tumors].

Authors:  M Schrader; M Hartmann; S Krege; K Miller; L Weissbach
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

2.  [What is most important is what comes across : Urological guidelines from the target group's point of view].

Authors:  J Busch; C Röllig; L Weissbach; C Kempkensteffen; S Hinz; C Jahnke; M Schostak; M Lein; S Weikert; C Stephan; S Deger; G Ollenschläger; K Miller; M Schrader
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

3.  Burden or relief: do second-opinion centers influence the quality of care delivered to patients with testicular germ cell cancer?

Authors:  Mark Schrader; Lothar Weissbach; Michael Hartmann; Susanne Krege; Peter Albers; Kurt Miller; Axel Heidenreich
Journal:  Eur Urol       Date:  2009-11-06       Impact factor: 20.096

4.  The surgical learning curve for prostate cancer control after radical prostatectomy.

Authors:  Andrew J Vickers; Fernando J Bianco; Angel M Serio; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
Journal:  J Natl Cancer Inst       Date:  2007-07-24       Impact factor: 13.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.